Carlos Eduardo Bernal Barquero

Dr. Carlos Eduardo Bernal Barquero

UNAM, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2018 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
MMMariano Martín
Mariano Martín
RGRomina Celeste Geysels
Romina Celeste Geysels
VPVictoria Peyret
Victoria Peyret
CBCarlos Eduardo Bernal Barquero
Carlos Eduardo Bernal Barquero
AMAna María Masini-Repiso
Ana María Masini-Repiso
JNJuan Nicola
Juan Nicola
Iodine is a crucial component of thyroid hormones; therefore, a key requirement for thyroid hormone biosynthesis is that iodide (I−) be actively accumulated in the thyroid follicular cell. The ability of the thyroid epithelia to concentrate I− is ultimately dependent on functional Na+/ I− Symporter (NIS) expression at the plasma membrane. Underscoring the significance of NIS for thyroid physiology, loss-of-function mutations in NIS-coding SLC5A5 gene cause I− transport defect resulting in dyshormonogenic congenital hypothyroidism. Moreover, I− accumulation in the thyroid cell constitutes the cornerstone for radioiodide ablation therapy for differentiated thyroid carcinoma. However, differentiated thyroid tumors often exhibit reduced (or even undetectable) I− transport compared to normal thyroid tissue, and are diagnosed as cold nodules on thyroid scintigraphy. Paradoxically, immunohistochemistry analysis revealed that most cold thyroid nodules express none, normal, and even higher NIS levels compared to adjacent normal tissue, but NIS is frequently intracellularly retained, suggesting the presence of post-translational abnormalities in the transport of the protein to the plasma membrane. Ultimately, a thorough comprehension of the mechanisms that regulate NIS transport to the plasma membrane would have multiple implications for radioiodide therapy, opening the possibility to identify new molecular targets to treat radioiodide-refractory thyroid tumors. Therefore, in this review, we will discuss the current knowledge regarding post-translational mechanisms that regulate NIS transport to the plasma membrane under physiological and pathological conditions affecting the thyroid follicular cell, a topic of great interest in the thyroid cancer field.

29 April 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MMMariano Martín
Mariano Martín
CMCarlos Pablo Modenutti
Carlos Pablo Modenutti
MRMauco Lucas Gil Rosas
Mauco Lucas Gil Rosas
VPVictoria Peyret
Victoria Peyret
RGRomina Celeste Geysels
Romina Celeste Geysels
JNJuan Nicola
Juan Nicola
Context Iodide transport defect (ITD) (Online Mendelian Inheritance in Man No. 274400) is an uncommon cause of dyshormonogenic congenital hypothyroidism due to loss-of-function variants in the SLC5A5 gene, which encodes the sodium/iodide symporter (NIS), causing deficient iodide accumulation in thyroid follicular cells. Objective This work aims to determine the molecular basis of a patient’s ITD clinical phenotype. Methods The propositus was diagnosed with dyshormonogenic congenital hypothyroidism with minimal 99mTc-pertechnetate accumulation in a eutopic thyroid gland. The propositus SLC5A5 gene was sequenced. Functional in vitro characterization of the novel NIS variant was performed. Results Sanger sequencing revealed a novel homozygous missense p.G561E NIS variant. Mechanistically, the G561E substitution reduces iodide uptake, because targeting of G561E NIS to the plasma membrane is reduced. Biochemical analyses revealed that G561E impairs the recognition of an adjacent tryptophan-acidic motif by the kinesin-1 subunit kinesin light chain 2 (KLC2), interfering with NIS maturation beyond the endoplasmic reticulum, and reducing iodide accumulation. Structural bioinformatic analysis suggests that G561E shifts the equilibrium of the unstructured tryptophan-acidic motif toward a more structured conformation unrecognizable to KLC2. Consistently, knockdown of Klc2 causes defective NIS maturation and consequently decreases iodide accumulation in rat thyroid cells. Morpholino knockdown of klc2 reduces thyroid hormone synthesis in zebrafish larvae leading to a hypothyroid state as revealed by expression profiling of key genes related to the hypothalamic-pituitary-thyroid axis. Conclusion We report a novel NIS pathogenic variant associated with dyshormonogenic congenital hypothyroidism. Detailed molecular characterization of G561E NIS uncovered the significance of KLC2 in thyroid physiology.

17 July 2019 in Thyroid®
Verified
Journal Article
Closed access
MMMariano Martín
Mariano Martín
CBCarlos Eduardo Bernal Barquero
Carlos Eduardo Bernal Barquero
RGRomina Celeste Geysels
Romina Celeste Geysels
PPPatricia Papendieck
Patricia Papendieck
VPVictoria Peyret
Victoria Peyret
JNJuan Pablo Nicola
Juan Pablo Nicola
Iodide transport defect (ITD) is an autosomal recessive disorder caused by deficient iodide accumulation into the thyroid follicular cell. ITD is an uncommon cause of dyshormonogenetic congenital hypothyroidism that results from inactivating mutations in the sodium/iodide symporter (NIS)-coding SLC5A5 gene. NIS is a key basolateral plasma membrane glycoprotein that efficiently mediates active iodide uptake in the thyroid—constituting the first step in the biosynthesis of the iodine-containing thyroid hormones—and other tissues, including salivary glands, lactating breast, and small intestine. The proposita, a 20-day-old female born in 1992, was diagnosed with congenital hypothyroidism through newborn screening. ITD was suspected on the basis of nondetectable radioiodide accumulation in a normally located nongoitrous thyroid gland, as well as in salivary glands. Sanger sequencing revealed nonpreviously reported compound heterozygous missense SLC5A5 gene variants (c.991G>A, p.D331N and c.1.641C>A, p.S547R). Notably, these variants have not been reported in public databases (i.e., Exome Aggregation Consortium, 1000 Genomes, and Single Nucleotide Polymorphism). In silico analysis using prediction softwares (i.e., SIFT, Polyphen-2, and MutationTaster2) support the pathologic significance of p.D331N and p.S547R NIS. Moreover, functional in vitro studies demonstrate that D331N and S547R NIS severely reduce iodide uptake when the proteins are heterologously expressed in HEK-293T cells because of a pronounced impairment of D331N and S547R NIS targeting to the plasma membrane. Of note, a charged residue at position 331 and a serine residue at position 547—which are highly conserved in SLC5A family members—are required for NIS plasma membrane targeting. We report two novel missense pathogenic variants in a compound heterozygous state in the SLC5A5 gene, detected through Sanger sequencing, in a pediatric female patient with dyshormonogenic congenital hypothyroidism.

14 March 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Monica Mata-MirandaMonica Mata-Miranda
Monica Mata-Miranda
CBCarlos Eduardo Bernal Barquero
Carlos Eduardo Bernal Barquero
AMAdriana Martínez-Cuazitl
Adriana Martínez-Cuazitl
CGCarla Ivonne Guerrero-Robles
Carla Ivonne Guerrero-Robles
VSVirginia Sánchez
Virginia Sánchez
Gustavo Vazquez-ZapienGustavo Vazquez-Zapien
Gustavo Vazquez-Zapien
Introduction. The acute kidney injury (AKI) is characterized by a sudden glomerular filtration reduction. Renal or intrinsic causes of AKI include nephrotoxicity induced by exogenous agents like cisplatin, which causes oxidative stress altering the biochemical process and leading to apoptosis. Therefore, this research is aimed at analyzing the embryonic stem cells (ESC) nephroprotective effect in AKI induced by cisplatin, employing genetic, phenotypic, and microspectroscopic techniques.Methods. Thirty mice were randomly divided into three groups (n=10): the healthy, isotonic salt solution (ISS), and mouse embryonic stem cells (mESC) groups. The ISS and mESC groups were subjected to AKI using cisplatin; 24 h post-AKI received an intraperitoneal injection of ISS or1×106mESC, respectively. At days 4 and 8 post-AKI, five mice of each group were sacrificed to analyze the histopathological, genetic (PDK4andHO-1), protein (p53), and vibrational microspectroscopic changes.Results.Histopathologically, interstitial nephritis and acute tubular necrosis were observed; however, the mESC group showed a more preserved microarchitecture with high cellularity. Additionally, the PDK4 and HO-1 gene expression only increased in the ISS group on day 4 post-AKI. Likewise, p53 was more immunoexpressed at day 8 post-AKI in the ISS group. About biomolecular analysis by microspectroscopy, bands associated with lipids, proteins, and nucleic acids were evidenced. Besides, ratios related to membrane function (protein/lipid), unsaturated lipid content (olefinic/total lipid, olefinic/total CH2, and CH2/CH3), and lipid peroxidation demonstrated oxidative stress induction and lipid peroxidation increase mainly in the ISS group. Finally, the principal component analysis discriminated against each group; nonetheless, some data of the healthy and mESC groups at day 8 were correlated.Conclusions. The mESC implant diminishes cisplatin nephrotoxicity, once the protective effect in the reduction of lipid peroxidation was demonstrated, reflecting a functional and histological restoration.

1 July 2021 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
MMMariano Martín
Mariano Martín
LSLisa Salleron
Lisa Salleron
VPVictoria Peyret
Victoria Peyret
RGRomina Celeste Geysels
Romina Celeste Geysels
EDElisabeth Darrouzet
Elisabeth Darrouzet
JNJuan Nicola
Juan Nicola

1 July 2019 in Nefrología
Verified
Journal Article
Open access
CBCarlos Eduardo Bernal Barquero
Carlos Eduardo Bernal Barquero
GVGustavo Jesús Vázquez-Zapién
Gustavo Jesús Vázquez-Zapién
MMMónica Maribel Mata-Miranda
Mónica Maribel Mata-Miranda